'Marketplace' Report: Cholesterol Chaos
Mar 31st, 2008 · Four cardiologists are telling doctors to stop prescribing two popular cholesterol drugs. They say the drugs might not work and recommend taking an older class of anti-cholesterol drugs.
Mar 31st, 2008 · Four cardiologists are telling doctors to stop prescribing two popular cholesterol drugs. They say the drugs might not work and recommend taking an older class of anti-cholesterol drugs.
Jan 15th, 2008 · This week, the makers of the drug Vytorin released a long-awaited study that raises questions about whether the drug has an impact in reducing the incidence of heart attacks and strokes. Dr. Stuart Seides has prescribed the drug to his patients selectively and says he will continue to do so despite the study.
Jul 11th, 2007 · Confirmation hearings are scheduled to be held Thursday for Dr. James Holsinger Jr., the Kentucky cardiologist nominated by President Bush to be the nation's 18th surgeon general. Holsinger is likely to face tough questioning -- not only about his own qualifications, but about whether he can stand up to the political meddling that his predecessor, Richard Carmona, says hampered his ability to do the job.
Jul 12th, 2006 · Commentator Darshak Sanghavi is a pediatric cardiologist. He has seen firsthand how a heart transplant can miraculously save a child's life. But he'll never forget the first time he watched how this second chance came from another child's tragedy.
Feb 15th, 2006 · Cardiologists described Harry Whittington's setback Tuesday as a silent heart attack. A shotgun pellet from last weekend's hunting accident traveled to his heart. Whittington's doctors have not specified what treatment they are administering.
Feb 14th, 2006 · Dr. Stuart F. Seides, associate director of cardiology at the Washington Hospital Center, discusses the potential cardiac care of Harry Whittington, the attorney who was accidentally shot Saturday by Vice President Dick Cheney. Whittington suffered a minor heart attack Tuesday.
Dec 5th, 2005 · A cardiologist testifies that drugmaker Merck had scientific evidence of Vioxx's cardiac hazards as far back as 1999 -- well before it pulled the drug from market in September 2004.